Technical Analysis for ALVR - AlloVir, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | N/A |
| Historical ALVR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 6.14% | |
| New 52 Week High | Strength | 6.14% | |
| Multiple of Ten Bullish | Other | 6.14% | |
| Up 3 Days in a Row | Strength | 6.14% | |
| New 52 Week Closing High | Bullish | 10.29% | |
| New 52 Week High | Strength | 10.29% | |
| Multiple of Ten Bearish | Other | 10.29% | |
| New 52 Week Closing High | Bullish | 25.44% | |
| New 52 Week Closing Low | Bearish | 30.22% | |
| Inside Day | Range Contraction | 30.22% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Biotechnology Biology Stem Cells Gene Therapy Cell Biology Cell Therapy Manufacturing Process Virus Viral Diseases Zoonoses
Biotechnology Biology Stem Cells Gene Therapy Cell Biology Cell Therapy Manufacturing Process Virus Viral Diseases Zoonoses
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 36.69 |
| 52 Week Low | 18.15 |
| Average Volume | 758,425 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs ) | N/A |
| Chandelier Exit (Short, 3 ATRs ) | N/A |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 41.71 | ||||
| Resistance 3 (R3) | 42.52 | 39.60 | 39.85 | ||
| Resistance 2 (R2) | 39.60 | 36.76 | 39.20 | 39.23 | |
| Resistance 1 (R1) | 35.08 | 35.01 | 37.34 | 34.27 | 38.61 |
| Pivot Point | 32.16 | 32.16 | 33.30 | 31.76 | 32.16 |
| Support 1 (S1) | 27.64 | 29.32 | 29.90 | 26.83 | 22.49 |
| Support 2 (S2) | 24.72 | 27.57 | 24.32 | 21.87 | |
| Support 3 (S3) | 20.20 | 24.72 | 21.25 | ||
| Support 4 (S4) | 19.39 |
